Eyevance Pharmaceuticals LLC

TX · United States · Reporting entity ID 100000501814

Total reported 2019–2025

$3.74M

#805 of 2,960 reporting companies — 0% of all reported industry payments

$1.93M in general payments across 20,805 records.

How it breaks down

General payments $1,927,398

Ownership & investment $1,808,700

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.